Actually, we could it is time to reheat the coffee kettle for another cup of stimulation
GLP-1s were associated with lower risk of new substance use disorder diagnoses Across alcohol, cannabis, cocaine, nicotine, opioids, and other drug categories, people who started a GLP-1 medication were less likely to receive a new substance use disorder diagnosis over the following 3 years relative to those who started the comparison diabetes medication, sodium-glucose cotransporter-2 inhibitor
Boehringer Ingelheims survodutide (glucagon/GLP-1), the first new competitor to enter the market outside the dominant Novo Nordisk/Lilly duopoly
Mechanism of Action Melanotan-II binds to melanocortin receptors, particularly MC1R on melanocytes in the skin
Youre in good hands
I mean that's a talent in of itself and she really helped so much with that